Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Autor: Grande, E. *, Capdevila, J., Castellano, D., Teulé, A., Durán, I., Fuster, J., Sevilla, I., Escudero, P., Sastre, J., García-Donas, J., Casanovas, O., Earl, J., Ortega, L., Apellaniz-Ruiz, M., Rodriguez-Antona, C., Alonso-Gordoa, T., Díez, J.J., Carrato, A., García-Carbonero, R.
Zdroj: In Annals of Oncology September 2015 26(9):1987-1993
Databáze: ScienceDirect